Literature DB >> 17550891

Temocillin susceptibility by BSAC methodology.

Jennifer M Andrews, Gail Jevons, Rebecca Walker, Janet Ashby, Adam P Fraise.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17550891     DOI： 10.1093/jac/dkm179

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

1.  Modelled Target Attainment after Temocillin Treatment in Severe Pneumonia: Systemic and Epithelial Lining Fluid Pharmacokinetics of Continuous versus Intermittent Infusions.

Authors:  N Layios; C Visée; V Mistretta; R Denooz; N Maes; J Descy; F Frippiat; S Marchand; N Grégoire
Journal:  Antimicrob Agents Chemother       Date:  2022-01-31       Impact factor: 5.938

Review 2.  Laboratory Detection and Clinical Implication of Oxacillinase-48 like Carbapenemase: The Hidden Threat.

Authors:  Yamuna Devi Bakthavatchalam; Shalini Anandan; Balaji Veeraraghavan
Journal:  J Glob Infect Dis       Date:  2016 Jan-Mar

3.  Activity of temocillin and 15 other agents, including fosfomycin and colistin, against Enterobacteriaceae in Hong Kong.

Authors:  Margaret Ip; Christopher K Lai; Kitty S C Fung; K-Tak Wong; Chendi Zhu; Sebastien Van de Velde; Dominic N Tsang; Peter Hawkey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-25       Impact factor: 3.267

4.  Clinical outcomes of temocillin use for invasive Enterobacterales infections: a single-centre retrospective analysis.

Authors:  Katie L Heard; Kieran Killington; Nabeela Mughal; Luke S P Moore; Stephen Hughes
Journal:  JAC Antimicrob Resist       Date:  2021-02-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.